Company intelligence / Profile preview

Bespoke Bioworks, Inc.

San Diego, California, United Statesgobioworks.com ↗

Ownership: Private
Development stage: Commercial

Overview

Bespoke Bioworks has developed a proprietary enzyme mix that enables the amplification of circular DNA molecules—such as plasmids and gene therapy vectors—without the use of E. coli or other cells. This approach overcomes limitations in traditional bacterial-based production methods, such as loss of important sequences like Poly A tails or ITRs in AAV vectors. The technology aims to improve throughput and reduce costs for next-generation genetic medicines.

Modalities: DNA circles (plasmids, gene therapy vectors)cell-free synthetic biology tools
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Bespoke Bioworks, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bespoke Bioworks, Inc..

Explore the full profile